-
Sector Analysis
Hepatitis B Virus (HBV) Therapeutics – 5EU Drug Forecast and Market Analysis to 2024
Chronic hepatitis B virus (HBV) infection is a serious chronic liver disease caused by the failure of viral clearance following acute HBV infection. Despite the availability of effective prophylactic vaccines, the disease remains a serious global health concern, with estimated over 350 million people worldwide currently living with this condition. In addition, patients with chronic hepatitis B are at a high risk of developing life-threatening complications including liver cirrhosis and hepatocellular carcinoma (HCC). In 2010, an estimated 786,000 HBV-related deaths...
-
Product Insights
Tinea pedis (Athlete Foot) Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Tinea pedis (Athlete Foot) Global Clinical Trials Review, H1, 2016" provides an overview of Tinea pedis (Athlete Foot) clinical trials scenario. This report provides top line data relating to the clinical trials on Tinea pedis (Athlete Foot). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Helminthiasis Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Helminthiasis Global Clinical Trials Review, H1, 2016" provides an overview of Helminthiasis clinical trials scenario. This report provides top line data relating to the clinical trials on Helminthiasis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Genital Warts (Condylomata Acuminata) Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Genital Warts (Condylomata Acuminata) Global Clinical Trials Review, H1, 2016" provides an overview of Genital Warts (Condylomata Acuminata) clinical trials scenario. This report provides top line data relating to the clinical trials on Genital Warts (Condylomata Acuminata). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Herpes Labialis (Oral Herpes) Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Herpes Labialis (Oral Herpes) Global Clinical Trials Review, H1, 2016" provides an overview of Herpes Labialis (Oral Herpes) clinical trials scenario. This report provides top line data relating to the clinical trials on Herpes Labialis (Oral Herpes). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Genital Herpes Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Genital Herpes Global Clinical Trials Review, H1, 2016" provides an overview of Genital Herpes clinical trials scenario. This report provides top line data relating to the clinical trials on Genital Herpes. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Cholera Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Cholera Global Clinical Trials Review, H1, 2016" provides an overview of Cholera clinical trials scenario. This report provides top line data relating to the clinical trials on Cholera. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Trypanosomiasis Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Trypanosomiasis Global Clinical Trials Review, H1, 2016" provides an overview of Trypanosomiasis clinical trials scenario. This report provides top line data relating to the clinical trials on Trypanosomiasis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Leishmaniasis (Kala-Azar) Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Leishmaniasis (Kala-Azar) Global Clinical Trials Review, H1, 2016" provides an overview of Leishmaniasis (Kala-Azar) clinical trials scenario. This report provides top line data relating to the clinical trials on Leishmaniasis (Kala-Azar). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Leprosy Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Leprosy Global Clinical Trials Review, H1, 2016" provides an overview of Leprosy clinical trials scenario. This report provides top line data relating to the clinical trials on Leprosy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.